EDITORIAL SECTION

Articles

Pharma Email Marketing Europe: Personalized Campaigns for C-Suite Leads

The pharmaceutical industry is a very competitive industry and to reach the decisionmakers a focused and strategic marketing strategy is necessary Conventional marketing is not often precise enough to reach executives that drive buying alliances and strategic relationships Here the pharma email marketing has come to play as a potent instrument of relationship establishment with the key stakeholder...

Pharma Event Marketing in Europe: Virtual & Hybrid Strategies to Drive High-Quality Leads

It is likely that you have attended some pharma event recently say in Frankfurt or Basel or even online and have noticed one thing Nothing wants lack of activity Booths are busy Webinars get registrations Virtual platforms show decent attendance numbers But when the dust settles a familiar problem shows up again

Data-Driven Pharma: Enterprise AI Strategies for R&D, Quality, and Operations

Few boardrooms in European pharma still need convincing that artificial intelligence matters The argument has moved on The uncomfortable question now facing chief executives chief scientific officers and heads of operations is why an organisation running eighty or ninety AI initiatives can rarely point to eighty or ninety changes in how it discovers releases or ships a medicine

Pharmaceutical Serialization in Europe: Ensuring Safety in the Supply Chain

Over the past few years however Europes pharmaceutical companies have faced a rather challenging role of fighting counterfeiting of medicines and therefore their patients Serialization it is a system that uses a special code assigned to every product has become one of the salient solutions to tackle counterfeit drugs While serialization in terms

Blockchain in Pharma: Strengthening Drug Traceability, Compliance, and Supply Chain Security

For most of the last decade the European pharmaceutical industry framed supply chain integrity as a packaging problem Put a unique identifier on every pack seal it with an antitampering device check it at the point of dispensing and the falsified medicine threat would be contained Since February that model has been law across the European Union and it has worked better than many sceptics predicte...

How AI Is Addressing Drug Development Challenges in Rare Diseases?

Healthcare struggles with persistent obstacles to treat and understand rare diseases which societies call orphan diseases While affecting a minority portion of individuals these rare diseases make therapy discovery difficult because of scarce research data and expensive evaluation costs alongside multifaceted disease pathways The rising use of artificial intelligence AI drives a transformative cha...

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys